XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow Reinvestment Rate
Latest as of December 2021:
0.00x
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow Reinvestment Rate of 0.00x as of December 2021, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $79.00K. Check XTL Biopharmaceuticals Ltd ADR (XTLB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$79.00K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for XTL Biopharmaceuticals Ltd ADR (None–None)
Year-by-year capital reinvestment analysis for XTL Biopharmaceuticals Ltd ADR. For live market cap and broader valuation context, see XTL Biopharmaceuticals Ltd ADR market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow